» Articles » PMID: 21327760

Cigarette Demand and Delayed Reward Discounting in Nicotine-dependent Individuals with Schizophrenia and Controls: an Initial Study

Overview
Specialty Pharmacology
Date 2011 Feb 18
PMID 21327760
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: The high prevalence of smoking and low cessation rates among individuals with schizophrenia and similar conditions are not well understood. Behavioral economics has been extensively applied to studying addictive behavior and may contribute to understanding smoking in this subpopulation.

Objectives: This study compared smokers with schizophrenia or schizoaffective disorder (SS) and control smokers (CS) on indices of cigarette demand and delayed reward discounting, a behavioral economic index of impulsivity.

Materials And Methods: The SS (n=25) and CS (n=24) groups participated in two sessions approximately 1 week apart. During the first session, delay discounting was assessed using the Monetary Choice Questionnaire. During the second session, participants smoked their usual brand ad libitum through a smoking topography assessment device, after which cigarette demand was assessed using a cigarette purchase task. Primary comparisons were of the hyperbolic discounting function, k, and indices of cigarette demand.

Results: Compared to the CS group, the SS group exhibited significantly higher intensity of demand, and significantly greater consumption and expenditure across the inelastic portion of the demand curve, but no differences were evident on the other demand indices. No differences were evident for delay discounting. The SS group also exhibited heavier smoking topography and two indices of smoking topography were significantly correlated with demand.

Conclusions: These results provide further evidence of higher incentive value of cigarettes among SS individuals, but not greater impulsivity, as measured by discounting. Considerations include potentially important methodological factors and the role of satiation/withdrawal.

Citing Articles

The Relationship Between Schizotypal Personality Traits and Temporal Discounting: The Role of the Date/Delay Effect.

Keidel K, Murawski C, Pantelis C, Ettinger U Schizophr Bull. 2025; 51(Supplement_2):S64-S73.

PMID: 40037816 PMC: 11879521. DOI: 10.1093/schbul/sbad110.


Neural dynamics underlying self-control in the primate subthalamic nucleus.

Pasquereau B, Turner R Elife. 2023; 12.

PMID: 37204300 PMC: 10259453. DOI: 10.7554/eLife.83971.


Characterizing Clinical Heterogeneity in a Large Inpatient Addiction Treatment Sample: Confirmatory Latent Profile Analysis and Differential Levels of Craving and Impulsivity.

Minhas M, Cooper A, Sousa S, Costello M, MacKillop J Subst Abuse. 2022; 16:11782218221126977.

PMID: 36385746 PMC: 9647308. DOI: 10.1177/11782218221126977.


Behavioral Economic Assessment of Alcohol and Cigarette Demand in Smokers With Alcohol Use Disorder.

Cui Y, Linares Abrego P, Yoon J, Karam-Hage M, Cinciripini P, Ait-Daoud Tiouririne N Front Psychiatry. 2021; 12:674607.

PMID: 34248711 PMC: 8260696. DOI: 10.3389/fpsyt.2021.674607.


No evidence of the clinical utility of single-item breakpoint to inform on tobacco demand in persons with substance use disorders.

Gonzalez-Roz A, Secades-Villa R, Aonso-Diego G, Weidberg S, Fernandez-Hermida J Psychopharmacology (Berl). 2021; 238(9):2525-2533.

PMID: 34031700 DOI: 10.1007/s00213-021-05875-y.


References
1.
Kirby K, Petry N, Bickel W . Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen. 1999; 128(1):78-87. DOI: 10.1037//0096-3445.128.1.78. View

2.
Perry J, Carroll M . The role of impulsive behavior in drug abuse. Psychopharmacology (Berl). 2008; 200(1):1-26. DOI: 10.1007/s00213-008-1173-0. View

3.
Bickel W, Marsch L, Carroll M . Deconstructing relative reinforcing efficacy and situating the measures of pharmacological reinforcement with behavioral economics: a theoretical proposal. Psychopharmacology (Berl). 2001; 153(1):44-56. DOI: 10.1007/s002130000589. View

4.
Williams J, Ziedonis D, Abanyie F, Steinberg M, Foulds J, Benowitz N . Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res. 2005; 79(2-3):323-35. DOI: 10.1016/j.schres.2005.04.016. View

5.
Jacobs E, Bickel W . Modeling drug consumption in the clinic using simulation procedures: demand for heroin and cigarettes in opioid-dependent outpatients. Exp Clin Psychopharmacol. 1999; 7(4):412-26. DOI: 10.1037//1064-1297.7.4.412. View